Top

BMC Infectious Diseases

Published in:

Open Access 01-12-2017 | Case report

Report of three imported cases of neurocysticercosis in Guadeloupe

Authors: R. Blaizot, B. Melot, K. Schepers, M. Nicolas, S. Gaumond, P. Poullain, L. Belaye, A. Lannuzel, B. Hoen

Published in: BMC Infectious Diseases | Issue 1/2017

Abstract

Background

Neurocysticercosis is endemic in most countries of Central and South America but has rarely been described in the French West Indies. We aimed to better understand the clinical and radiological presentation of our cases.

Case presentation

We report three cases of neurocysticercosis in patients living in Guadeloupe, with different clinical and radiological presentations.

Conclusion

Given the eventuality of autochtonous transmission, the diagnosis should be considered in all patients living in Guadeloupe presenting with seizures.

Available only for authorised users

Montano SM, Villaran MV, Ylquimiche L, Figueroa JJ, Rodriguez S, Bautista CT, et al. Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology. 2005;65:229–33.CrossRefPubMed

Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol. 2014;13:1202–15.CrossRefPubMed

Nicoletti A, Bartoloni A, Sofia V, Bartalesi F, Chavez JR, Osinaga R, et al. Epilepsy and neurocysticercosis in rural Bolivia: a population-based survey. Epilepsia. 2005;46:1127–32.CrossRefPubMed

Medina MT, Durón RM, Martínez L, Osorio JR, Estrada AL, Zúniga C, et al. Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salamá Study. Epilepsia. 2005;46:124–31.CrossRefPubMed

Del Brutto OH. Neurocysticercosis. Contin Minneap Minn. 2012;18:1392–416.

Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian Y-J, Rainwater E, et al. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis. 2010;4, e870.CrossRefPubMedPubMedCentral

Endemicity_Taenia_Solium_2015.jpg (JPEG Image, 3513 × 2479 pixels) - Scaled (29%) [Internet]. [cited 2016 Jul 1]. Available from: http://www.who.int/taeniasis/Endemicity_Taenia_Solium_2015.jpg?ua=1

Fabiani S, Bruschi F. Neurocysticercosis in Europe: Still a public health concern not only for imported cases. Acta Trop. 2013;128:18–26.CrossRefPubMed

Raccurt CP, Agnamey P, Boncy J, Henrys J-H, Totet A. Seroprevalence of human Taenia solium cysticercosis in Haiti. J Helminthol. 2009;83:113–6.CrossRefPubMed

10.

Sanon NT, Rivera Meija D, Santos VD. 30th International Epilepsy Congress, Montreal, Canada, 23–27 June, 2013. Epilepsia. 2013;54:4–29.CrossRef

11.

World Health Organization. Working to overcome the global impact of neglected tropical diseases: first WHO report on neglected tropical diseases. Geneva: Department of Reproductive health and Research, World Health Organization; 2010.

12.

Caparros-Lefebvre D, Lannuzel A, Alexis C, Strobel M, Janky E. Cerebral cysticercosis: why it should be treated. Presse Médicale Paris Fr. 1997;26:1574–7.

13.

Roudier M, Maillard A, Brousse D, David T, Huerre M. Cysticercosis in Guadeloupe. Ann Pathol. 2000;20:238–40.PubMed

14.

Del Brutto OH, Rajshekhar V, White AC, Tsang VC, Nash TE, Takayanagui OM, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. 2001;57:177–83.CrossRefPubMedPubMedCentral

15.

Del Brutto OH. Diagnostic criteria for neurocysticercosis, revisited. Pathog Glob Health. 2012;106:299–304.CrossRefPubMedPubMedCentral

16.

Baird RA, Wiebe S, Zunt JR, Halperin JJ, Gronseth G, Roos KL. Evidence-based guideline: treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;80:1424–9.CrossRefPubMedPubMedCentral

17.

Yera H, Dupont D, Houze S, Ben M’rad M, Pilleux F, Sulahian A, et al. Confirmation and follow-up of neurocysticercosis by real-time PCR in cerebrospinal fluid samples of patients living in France. J Clin Microbiol. 2011;49:4338–40.CrossRefPubMedPubMedCentral

18.

Cantú C, Barinagarrementeria F. Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol. 1996;53:233–9.CrossRefPubMed

19.

Marquez JM, Arauz A. Cerebrovascular complications of neurocysticercosis. Neurologist. 2012;18:17–22.CrossRefPubMed

20.

Brutto OHD, García HH. Cysticercosis of the Human Nervous System. Springer Science & Business Media. 2013.

21.

Singh G, Prabhakar S. Taenia Solium Cysticercosis: From Basic to Clinical Science. CABI. 2002.CrossRef

22.

Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology. 2002;59:1730–4.CrossRefPubMed

23.

Carpio A, Kelvin EA, Bagiella E, Leslie D, Leon P, Andrews H, et al. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2008;79:1050–5.CrossRefPubMed

24.

Garcia HH, Lescano AG, Gonzales I, Bustos JA, Pretell EJ, Horton J, et al. Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2016;62:1375–9.CrossRef

25.

Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004;350:249–58.CrossRefPubMed

26.

Poeschl P, Janzen A, Schuierer G, Winkler J, Bogdahn U, Steinbrecher A. Calcified neurocysticercosis lesions trigger symptomatic inflammation during antiparasitic therapy. AJNR Am J Neuroradiol. 2006;27:653–5.PubMed

27.

Romo ML, Carpio A, Kelvin EA. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel? J Clin Pharmacol. 2014;54:361–7.CrossRefPubMed

28.

Sharma LN, Garg RK, Verma R, Singh MK, Malhotra HS. Seizure recurrence in patients with solitary cystic granuloma or single parenchymal cerebral calcification: a comparative evaluation. Seizure. 2013;22:840–5.CrossRefPubMed

29.

García HH, Gonzalez AE, Rodriguez S, Tsang VCW, Pretell EJ, Gonzales I, et al. Neurocysticercosis: unraveling the nature of the single cysticercal granuloma. Neurology. 2010;75:654–8.CrossRefPubMedPubMedCentral

30.

Chang KH, Han MH. MRI of CNS parasitic diseases. J Magn Reson Imaging JMRI. 1998;8:297–307.CrossRefPubMed

31.

García HH, Del Brutto OH. Imaging findings in neurocysticercosis. Acta Trop. 2003;87:71–8.CrossRefPubMed

32.

Lescano AG, Garcia HH, Gilman RH, Guezala MC, Tsang VCW, Gavidia CM, et al. Swine cysticercosis hotspots surrounding Taenia solium tapeworm carriers. Am J Trop Med Hyg. 2007;76:376–83.PubMed

33.

Devleesschauwer B, Allepuz A, Dermauw V, Johansen MV, Laranjo-González M, Smit GSA, et al. Taenia solium in Europe: Still endemic? Acta Trop. 2015.

34.

Del Brutto OH. Neurocysticercosis in infants and toddlers: report of seven cases and review of published patients. Pediatr Neurol. 2013;48:432–5.CrossRefPubMed

35.

Lescano AG, Garcia HH, Gilman RH, Gavidia CM, Tsang VCW, Rodriguez S, et al. Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis. 2009;3, e371.CrossRefPubMedPubMedCentral

36.

Gilman RH, Del Brutto OH, García HH, Martínez M. Prevalence of taeniosis among patients with neurocysticercosis is related to severity of infection. TheCysticercosis Working Group in Perú Neurology. 2000;55:1062.PubMed

37.

García HH, Del Brutto OH. Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú. Neurology. 1999;53:1582–4.CrossRefPubMed

38.

Allan JC, Avila G, Garcia Noval J, Flisser A, Craig PS. Immunodiagnosis of taeniasis by coproantigen detection. Parasitology. 1990;101(Pt 3):473–7.CrossRefPubMed

Title: Report of three imported cases of neurocysticercosis in Guadeloupe
Authors: R. Blaizot
B. Melot
K. Schepers
M. Nicolas
S. Gaumond
P. Poullain
L. Belaye
A. Lannuzel
B. Hoen
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/s12879-016-2169-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Report of three imported cases of neurocysticercosis in Guadeloupe

Abstract

Background

Case presentation

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Case presentation

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2017

Factors associated with stigma attitude towards people living with HIV among general individuals in Heilongjiang, Northeast China

A case report of co-infection of Melioidosis and cutaneous Leishmaniasis

Invasive anisakiasis by the parasite Anisakis pegreffii (Nematoda: Anisakidae): diagnosis by real-time PCR hydrolysis probe system and immunoblotting assay

Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death

Vitamin D and activated vitamin D in tuberculosis in equatorial Malaysia: a prospective clinical study

ICARES: a real-time automated detection tool for clusters of infectious diseases in the Netherlands

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page